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Summary:  57 
Reasons for performing the study: A recent survey of European Colleges (ECEIM and 58 
ECVS) revealed the different strategies implemented by, and some of the challenges 59 
facing, European clinicians presented with cases of POI.  It was concluded that further 60 
comparative analysis of opinions, canvassed from additional colleges of equine 61 
veterinary specialism worldwide, would provide valuable additional insight into current 62 
POI knowledge on a more global scale. 63 
Objectives:  To report and compare the current strategies favoured by American 64 
veterinary specialists when managing postoperative ileus (POI) in horses that underwent 65 
emergency colic surgery.    66 
Methods: Electronic invitations were sent to 814 Large Animal specialists, including 3 67 
colleges: the ACVIM, the ACVS and the ACVECC.   68 
Results:  The response rate was 14% (115/814).  The most common prevalence range of 69 
POI reported was 11 to 20%. The presence of reflux on nasogastric intubation was the 70 
main criterion used to define POI.  A lesion involving the small intestine was considered 71 
the main risk factor for POI.  Anti-inflammatory drugs, intravenous fluids and 72 
antimicrobial drugs were the primary strategies used when managing POI.  Flunixin 73 
meglumine and intravenous (IV) lidocaine were the drugs most commonly used in the 74 
treatment of horses with POI.  Supplementary management strategies targeted mainly the 75 
prevention of postoperative adhesions, infection and inflammation.  76 
Conclusions:  There is a lack of consensus on the clinical definition of POI.  Prospective 77 
and objective clinical assessment of the effectiveness of the different strategies contained 78 
within this and the European survey is necessary in order to identify a standardized 79 
approach to the management of equine POI.  80 
Introduction:  81 
This study constitutes an extension of work, previously targeting specialist European 82 
equine veterinary clinicians (ECVS and ECEIM diplomates)1, which investigated the 83 
different strategies used to define, prevent, and treat equine POI and the variation in 84 
awareness of the published risk factors for this condition.  A general article detailing that 85 
original survey was published in 2014 in the Equine Veterinary Journal1.  The data 86 
derived from that original study revealed valuable information on the different strategies 87 
implemented by, and some of the challenges facing, European clinicians presented with 88 
cases of POI.  It was concluded that further comparative analysis of opinions, canvassed 89 
from additional colleges of equine veterinary specialism worldwide, would provide 90 
valuable additional insight into current POI knowledge on a more global scale.  91 
This survey was aimed at identifying and assessing the opinions and practices of 92 
specialist American equine veterinary clinicians in relation to POI. The principal areas 93 
which were investigated included the following: (a) an assessment of respondents’ 94 
awareness of underlying pathophysiological mechanisms and associated risk factors; (b) 95 
estimated incidence of POI; (c) the adopted clinical definitions; (d) preferred 96 
pharmacological and non-pharmacological management strategies.  97 
This study also permitted a more detailed assessment of opinions relating to certain  98 
factors previously identified in the European survey1 which were considered to be 99 
important contributors to POI prevention, diagnosis and treatment.  100 
When considered in isolation, the data derived from this survey provides an overview of 101 
the opinions and practices of American equine specialists. When compared with the 102 
results of the European1 survey, it highlights specific areas of commonality and 103 
heterogeneity in those opinions and practices.  When combined with the results of the 104 
European survey, it provides a robust international perspective on the opinions and 105 
practices of equine veterinary specialists. 106 
 107 
Material and methods  108 
Ethical approval for this study was granted by the University of Edinburgh, School of 109 
Veterinary Medicine Ethical Review Committee.  110 
The original European survey’s questionnaire was tested with 3 American surgeons and 111 
internists. Minor adjustments were implemented and consisted mainly of adapting certain 112 
medication nomenclature from the European to the American practice environment (e.g. 113 
lignocaine to lidocaine). The questionnaire (see Supplementary Information) consisted of 114 
27 open-ended (e.g. comments, descriptions) and closed (e.g. Likert scales, multiple 115 
choices) questions and was designed to permit completion within a period of 10-15 116 
minutes.  The questions addressed the same general items as in the original European 117 
survey. 118 
The survey was integrated in a web-based proprietary softwarea program. An invitation to 119 
participate was sent by e-mail to 814 Large Animal specialist veterinary clinicians, 120 
Diplomates of one (or two) of the, following 3 colleges: the ACVIM (n=531), ACVS 121 
(n=283) and the ACVECC (n=43; all with dual membership of either ACVIM or ACVS). 122 
First, second and third reminders were sent at 2 weekly intervals if a response was not 123 
obtained.  Responses were included in this report only if the questionnaire was fully 124 
completed within an 8-week period.  125 
Statistical analysis was generated from the online survey software programa. These 126 
included respondent numbers, percentages and frequency tables. Some common themes 127 
were identified based on the responses provided to specific open questions. The most 128 
common comments originating from the open ended questions were categorized and 129 
tabulated in the results section.  Unless stated otherwise, the percentages expressed in the 130 
results reflected the proportion of the total number of responses obtained and were 131 
rounded up to the nearest whole number.   132 
 133 
Results  134 
Respondent data and practice demographics: Responses were obtained from 115 out of 135 
the 814 invited participants (response rate = 14%). These comprised those with sole 136 
ACVS (n=55) or ACVIM membership (n=44) and those with dual ACVIM and ACVS 137 
(n=1), ACVIM and ACVECC (n=4) and ACVS and ACVECC (n=11) membership. The 138 
median range of annual equine caseload at the respondents’ clinic was between 2001-139 
3000 cases.  Almost a third of respondents (29%) reported between 300 and 399 140 
combined medical and surgical colic cases per annum. The number equine colic surgery 141 
per annum was almost evenly divided between the six different categorical answer 142 
options from 1-20 to > 100 (see Supplementary Information, Figure 1). 143 
Estimated POI prevalence and definition criteria: Sixty eight per cent of respondents 144 
(68%) estimated the prevalence of POI following colic surgery at their respective clinics 145 
to be in the range of 0-20%. There were fewer than 5% of respondents reporting a 146 
prevalence of POI > 40% (See Supplementary Information, Figure 2). Sixty four percent 147 
of respondents (64%) ‘do not’ use a hospital/practice protocol for the definition of POI. 148 
Ninety-four percent (94%) of respondents considered that presence of reflux on 149 
nasogastric intubation was extremely important in classification of a horse having POI 150 
(Table 1), with volumes of ≥ 4 litres at any given intubation (37% of respondents) and >2 151 
litres/hour on repeated intubations (35% of respondents) representing the most commonly 152 
applied criteria with respect to POI definition (Figure 1).  153 
Table 1: ACVS, ACVIM and ACVECC Diplomates’ rating of the importance of different parameters 154 
in the diagnostic classification of POI from an online questionnaire of the Clinical Features and 155 
Management of Equine POI, completed by 115 respondents                                156 
 
Diagnostic classification of POI parameter 
’%  
‘Extremely 
Important’ 
% 
‘Quite 
Important’ 
% 
‘Not very 
Important’ 
% 
‘Not important 
at  all’ 
Presence of reflux on nasogastric intubation 94 6 0 0 
Ultrasonographic evidence of multiple fluid distended SI bowel 
loops 
67 28 3 2 
Evidence of multiple fluid distended SI loops on rectal 
examination 
45 45 10 0 
Mild to moderate signs of abdominal discomfort 28 48 24 2 
Deterioration of cardiac parameters (tachycardia) 21 48 28 2 
Ultrasonographic evaluation of the motility of other SI parts 38 42 19 3 
Ultrasonographic evaluation of duodenal motility 29 41 26 4 
Fever 4 17 59 22 
Absence of GI sounds 12 39 43 6 
Bolded: Most common answer 157 
Figure 1: ACVS, ACVIM and ACVECC Diplomates’ postoperative reflux volume corresponding most to 158 
respondents’ own working definition of POI from an online questionnaire of the Clinical Features and 159 
Management of Equine POI completed by 115 respondents 160 
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Perceived risk factors: A lesion involving the small intestines (SI) (70% of respondents) 170 
was considered ‘extremely important’ as a pre- and intra-operative risk factor for 171 
developing POI (Table 2) with the presence of SI distension (69% of respondents) and 172 
inflammation (57%) considered the most important postoperative risk factors (Table 3).  173 
Table 2: ACVS, ACVIM and ACVECC Diplomates’ rating of the importance of potential pre- and 174 
intra-operative risk factors for the development of POI from an online questionnaire of the Clinical 175 
Features and Management of Equine POI, completed by 115 respondents      176 
 
Pre- and intra-operative risk factors 
 
% 
‘Extremely 
Important’ 
% 
‘Quite 
Important’ 
% 
‘Not very 
Important’ 
% 
‘Not important 
at  all’ 
Lesions involving the SI 70 27 3 0 
Intestinal resection and anastomosis 64 29 7 0 
Degree of bowel distension at surgery 62 36 3 0 
Increased amount of bowel handling 60 33 7 0 
Presence of discolored bowel at surgery 52 41 7 0 
Endotoxaemia (clinical or lab evidence of) 29 61 11 0 
Increased blood lactate level pre-op 15 57 25 4 
Increased packed cell volume (PCV) at admission 10 48 36 6 
Long anaesthesia and surgery duration 35 46 19 0 
Abnormal bowel motility observed at surgery 34 45 20 1 
Long-time between referral and admission of colic case 36 43 18 3 
Administration of opioids as pain medication  4  13   54  29 
Bolded: Most common answer  177 
Table 3:  ACVS, ACVIM and ACVECC Diplomates’ rating of the importance of potential 178 
postoperative risk factors for the development of POI from an online questionnaire of the Clinical 179 
Features and Management of Equine POI, completed by 115 respondents                               180 
 
Postoperative risk factors 
% 
‘Extremely 
Important’ 
% 
‘Quite 
Important’ 
% 
‘Not very 
Important’ 
% 
‘Not important 
at  all’ 
SI distention 69 31 0 0 
Inflammation 57 40 3 0 
Abdominal pain 21 61 17 2 
Interval to commencement of post-op feeding 16 50 30 6 
Gastric distention 27 47 26 0 
Postoperative  adhesions 35 46 18 2 
Infection 29 42 29 2 
Leaving NG tube indwelling 7 25 59 8 
Volume and type of intravenous fluids given 5 28 57 10 
Postoperative pain medication (opioids) 7 25 57 11 
Interval to commencement of post-op exercise 5 28 53 13 
Bolded: Most common answer 181 
 182 
Preventive strategies: Approximately half of respondents (52%) stated that their 183 
hospital/practice used a defined protocol in an attempt to prevent POI intra- and 184 
postoperatively.  Anti-inflammatory drugs (99% of respondents), intravenous fluids 185 
(92%), antimicrobial drugs (87%), electrolyte supplementation of fluids (68%), early 186 
exercise (47%) and early feeding (32%) were the most commonly employed POI 187 
preventive strategies ‘in all surgical colic cases’, whereas over half (56%) of respondents 188 
stated that opioid administration was used ‘only in the minority of cases considered at 189 
risk for POI’.  Flunixin meglumine (72% of respondents ‘in all surgical colic cases’) and 190 
intravenous (IV) lidocaine (40% ‘in all surgical colic cases considered at risk for POI’) 191 
were the drugs most commonly used intra-operatively in surgical colic cases to prevent 192 
POI.  Similarly, flunixin meglumine (87% ‘in all surgical colic cases’) and IV lidocaine 193 
(57% ‘in all surgical colic cases considered at risk for POI’) were the drugs most 194 
commonly used postoperatively in surgical colic cases to prevent POI.  Although 31% of 195 
respondents used polymixin B postoperatively ‘in the majority of cases considered at risk 196 
for POI’, the same percentage (31%) only used this approach ‘in the minority of surgical 197 
colic cases considered at risk for POI’. Similarly, metoclopramide (53%), butorphanol 198 
(46%), xylazine (44%) and plasma containing anti-lipopolysaccharide (LPS) antibodies 199 
(37%) were mostly used postoperatively ‘in the minority of surgical colic cases 200 
considered at risk for POI’. 201 
Treatment strategies: Just over half of the respondents (55%) followed a hospital/practice 202 
protocol for the treatment of surgical cases that developed POI. When asked about the 203 
pharmacological management of such cases, the respondents again favored flunixin 204 
meglumine (77%) and IV lidocaine (69%) ‘in all POI cases’. In comparison, 205 
metoclopramide (57%), butorphanol (50%), heparin (49%), plasma containing anti –LPS 206 
(43%) and polymyxin B (41%) were the most common choices ‘in a few POI cases’.  207 
The majority of respondents (90%) favored flunixin meglumine as their nonsteroidal anti-208 
inflammatory drug of choice. Forty six percent of these respondents (36/78) specified a 209 
dosage of 1.1 mg/kg IV, and 33% (26/78) administered at this dose rate twice daily.  210 
Other dose rates used included 0.5 mg/kg IV (14%, 11/78) and 0.25 mg/kg IV (9%, 7/78), 211 
at varying frequencies (twice, three or four times daily).  212 
When asked about their favored dosage regimen when using lidocaine in the 213 
postoperative treatment of POI cases, most of the 115 respondents commented: 1.3mg/kg 214 
bolus followed by a constant rate infusion (CRI) rate of 0.05 mg/kg/min (60%); a lower 215 
proportion (11%) used the same CRI rate but ‘with no loading dose’.  Twelve per cent of 216 
the respondents (12%) mentioned that they use IV lidocaine ‘as indicated/published’. 217 
Supplementary strategies: Comments about supplementary strategies used to avoid or 218 
minimise exposure to intra-operative risk factors for POI or other colic surgery-related 219 
complications included the prevention of postoperative adhesions (105 comments), 220 
infection (77 comments) and inflammation (62 comments). Adhesion prevention 221 
protocols included the use of intra-abdominal carboxymethylcellulose (59% of 222 
comments, 62/105), abdominal lavage + heparin (39%, 41/105) and careful/minimal 223 
manipulation of the bowel (9%, 10/105). Infection prevention protocols included the use 224 
of systemic antimicrobials (61% of comments, 47/77) and abdominal lavage with 225 
antimicrobial-containing fluids (34%, 26/77). Comments about inflammation prevention 226 
protocols included the use of anti-inflammatory drugs (44% of comments, 25/62); 227 
specifically flunixin meglumine (35%, 22/62), careful handling/surgical technique (13%, 228 
8/62), IV lidocaine (11%, 7/62) and dimethyl sulfoxide (DMSO), (10%, 6/62). 229 
The supplementary postoperative strategies utilized to prevent and manage POI were, in 230 
decreasing order of frequency: gastric decompression via nasogastric intubation (86% of 231 
respondents), judicious timing of feeding (85%), hand-walking exercise (84%), use of 232 
antibiotics (83%), control of endotoxaemia (76%), fluid therapy (69%) and other 233 
strategies (26%).  In relation to gastric decompression via nasogastric intubation of POI 234 
cases, 58% of respondents left the tube indwelling; although 57% (38/66) of those 235 
commented that it was ‘case dependent’ and 41% (27/66) mentioned: ‘only if the patient 236 
is refluxing’.   237 
When asked to comment further on the ‘judicious timing of feeding’, most of the 238 
respondents (85%, 98/115) stated: ‘start slowly/in small quantities’ (32%, 31/98), ‘within 239 
24 hours postoperatively’ (29%, 28/98),  ‘grazing/grass is best’ (28%, 27/98), ‘feeding as 240 
soon as possible’ (21%, 20/98), ‘feed when no more reflux’ (12%, 12/98) and ‘place hay 241 
net outside the stall’ (11%, 11/98). More detailed comments relating to the introduction 242 
of hand-walking exercise (97) included: ‘as soon as possible along with early feeding’ 243 
(28%, 27/97), ‘within 24 hours postoperatively’ (24%, 23/97), ‘implemented routinely’ 244 
(10%, 10/97) and ‘start 2 days postoperatively’ (9%, 9/97). 245 
Fluid therapy and parenteral nutrition: In POI cases, the majority of respondents (67%) 246 
opted for the administration of fluid therapy at maintenance rates and most (59%) used 247 
polyionic resuscitation fluids ‘in all POI cases’.  The most common intravenous fluid 248 
supplements used in cases that have developed POI were: calcium (64% of respondents) 249 
and potassium (64%) ‘routinely’ and magnesium (60%) ‘depending on clinical pathology 250 
results’.  In POI cases, 52% of respondents used total parenteral nutrition (TPN) ‘only in 251 
a few cases’, 46% of respondents ‘never’ used TPN and 67% used partial parenteral 252 
nutrition (PPN), but only ‘in a few cases’. Of the 48 comments relating to the use of TPN 253 
and PPN, 88% (42/48) included the use of dextrose, 67% (32/48) the addition of amino 254 
acids and, 23% (11/48) mentioned the high cost limitations of such therapy. 255 
 Repeat surgery: In POI cases, the majority of respondents (91%) said they would 256 
consider a second laparotomy. Of those respondents, 38% (40/104) expressed their 257 
preferred inter-operative time interval to be 2 to 4 days, closely followed by 4-6 days 258 
(29%, 30/104). 259 
 260 
Discussion  261 
This survey is based on the opinions of 115 Diplomates of three American veterinary 262 
medicine and surgery colleges on the description, prevention and treatment of equine 263 
POI. With the aim to include as many specialist opinions as possible, the population’s 264 
criteria for this study consisted of all Diplomates of the ACVS, ACVIM and ACVECC 265 
listed under large animal (LA). Although our response rate may be considered low, a 266 
significant proportion of contacted Diplomates would be ineligible for our study.  Despite 267 
recognising that the survey’s specific theme (i.e. POI following emergency colic surgery) 268 
would render a  proportion  of the 814 Diplomates ineligible, no alternative means were 269 
implemented in order to specifically focus on eligible Diplomates.  Hence, in addition to 270 
eligible surgeons and clinicians that failed to respond, the non-responders for this study 271 
may have included farm animal specialists, field-service or general practitioners, 272 
orthopaedic surgeons, and diplomates with a primarily research-based career.  The 273 
absolute number of respondents from this current survey (115: 67 ACVS + 48 ACVIM) 274 
was comparable with similar published surveys and target audiences; e.g. Lefebvre et al. 275 
2014 survey (100 respondents from the ECVS and ECEIM; 30% response rate) and the 276 
Van Hoogmoed 2004 survey (58 respondents from the ACVS; 52% rate) 1,2. 277 
Consequently, it could be argued that the responses obtained were not representative of 278 
the entire population surveyed but rather represent the opinions of a subgroup of 279 
veterinary clinicians and surgeons actively involved in equine abdominal surgery and 280 
POI management. 281 
Comparisons made between the American and European1 surveys largely revealed a high 282 
level of agreement in the responses obtained which further highlighted a number of areas 283 
in which there is potential for improvement in the understanding and knowledge of 284 
equine POI.  285 
Firstly, the most commonly estimated POI prevalence range in both surveys (European - 286 
71%; American - 68%) was 0 to 20%. This “estimated” prevalence range falls within the 287 
lower ranges of “measured” prevalence derived from various other studies (i.e. 10%-288 
50%) 2,3,4,5.  Although this finding could indicate a decline in incidence of POI it may 289 
also reflect inaccuracies in the prevalence estimates provided by the respondents. 290 
Then, there was inconsistency among respondents with regard to the specific criteria used 291 
to define POI.  Although the presence of gastric reflux was still regarded as the most 292 
important criterion for defining POI6,7, there was variation amongst respondents in 293 
relation to the volume and rate of yield of fluid considered to be diagnostic. Similar to the 294 
European study1, almost three quarters of respondents applied the criteria of either > 4 295 
litres at any given intubation or a rate of >2 litres/hour on repeated intubations, with 296 
almost one quarter applying the criterion of > 2 litres at any given intubation. Matter-of-297 
factly, the latter criterion was applied by 34% (13/38) of the respondents who reported an 298 
estimated prevalence rate >20%, a finding which may highlight the significant influence 299 
of varied POI definition criteria on reported prevalence.  300 
Also, the pre-, intra- and postoperative factors considered as ‘extremely important’ with 301 
respect to their contribution to POI were identical to those identified in the European 302 
study1, indicative of a general awareness of the risk factors published in the veterinary 303 
literature 1,3,8,9,10,11.  Likewise, the administration of opioids as an analgesic in the pre- 304 
and/or intra-operative as well as in the postoperative periods was  largely perceived as 305 
’not very important’ in both studies with respect to its contribution to POI. Moreover, this 306 
survey also demonstrated overall support amongst clinicians for the development and use 307 
of general ‘in-house’ guidelines for perioperative care strategies aimed at preventing and 308 
treating POI, similar to those applied in human medicine12.  309 
There was also agreement between studies in relation to the preferred drugs of choice. 310 
Both survey studies, and that of Van Hoogmoed et al. (2004), identified IV lidocaine as 311 
the most common prokinetic drug of choice, with relative consistency in the dosage 312 
regimen used1,2. Similarly, both studies identified metoclopramide as the second most 313 
common prokinetic drug of choice for either intra-operative preventive or postoperative 314 
therapeutic use, a finding in contrast to the results of the Van Hoogmoed et al. (2004) 315 
survey2, whereby erythromycin lactobionate was the second most popular choice.  316 
Although both studies identified lidocaine and flunixin as the 2 most popular drugs for 317 
the prevention and treatment of POI, when compared to the European survey (IV 318 
lidocaine 78% vs flunixin 78%), IV lidocaine  appeared to be less popular (68%) relative 319 
to flunixin (77%) in the American survey for the treatment of POI cases. The use of 320 
flunixin concurs with the general perception amongst both European and American 321 
respondents that inflammation is an ‘extremely important’ postoperative risk factor for 322 
the development of POI, second only to the presence of SI distension. This likely reflects 323 
an awareness of the increasing body of published evidence supporting a pivotal role for 324 
inflammation in equine POI pathogenesis3,13,14,15,16.  Similarly, it is likely that the 325 
reported anti-inflammatory effects of lidocaine 17,18,19, in addition to its perceived 326 
prokinetic effects2, also contributed to the high frequency with which this drug was used, 327 
both intra- and postoperatively. Furthermore, in addition to inflammation, pain is 328 
recognised as an important risk factor for POI in both humans and horses1,2,6,9,12,19. The 329 
specific reasons why flunixin was the preferred non-steroidal anti-inflammatory drug 330 
(NSAIDs) remain uncertain; however, its reportedly greater potency against the systemic 331 
effects of endotoxaemia17, compared with other NSAIDs, may be a contributing factor in 332 
light of the respondents perception that endotoxaemia was “quite important” as a risk 333 
factor for the development of POI.  334 
Despite the many similarities in results between the European and American surveys, 335 
there were certain areas where the responses differed. Firstly, although anti-inflammatory 336 
drugs were selected in both surveys as those most commonly used for POI 337 
prevention/management, in the American survey they were followed in decreasing 338 
frequency of use by intravenous fluid administration, antimicrobial drugs and electrolyte 339 
supplementation; whereas, in the European study, they were followed by antimicrobial 340 
drug administration and, to a lesser extent, prokinetic drugs1. Secondly, the American 341 
survey revealed a tendency for clinicians to retain an indwelling nasogastric tube after 342 
surgery (58% of respondents), although further comments clarified that this decision was 343 
case-dependant, e.g. only if the patient is refluxing or according to clinical signs. In 344 
comparison, the majority of European respondents (70%) preferred to pass the 345 
nasogastric tube only as required1. Thirdly, despite the American survey revealing that 346 
parenteral nutrition was used ‘only in a few POI cases’, in such cases, approximately half 347 
and two thirds of the respondents stated that they would use TPN and PPN, respectively. 348 
This is in contrast to the European survey1 in which approximately half of the 349 
respondents stated that they would consider the use of PPN ‘only in a few POI cases’ and 350 
almost three quarters of respondents stated that they would “never use TPN”. Lastly, 351 
despite an almost identical proportion of respondents from each survey stating that they 352 
would consider a repeat laparotomy in refractory cases (European - 88% vs American - 353 
91%), a comparatively lower proportion of respondents in the American survey (38%), 354 
relative to the European survey (46%) opted for 2 to 4 days and a comparatively higher 355 
proportion of respondents in the American survey (29%) relative to the European survey 356 
(15%) opted for 4-6 days as the preferred timing of the second surgery relative to the 357 
first. The specific reasons for these apparent geographical differences remain unclear; 358 
however, it is possible that they are largely attributable to factors such as financial 359 
constraints and the presence of established practice policy. However the authors can find 360 
no evidence base within the veterinary literature which will preferentially support one 361 
approach over another.  362 
The analysis of data derived from this survey of Equine Veterinary Diplomates of 363 
American Colleges has provided an overview of the commonly held perceptions related 364 
to various aspects of equine POI.  Furthermore, comparative analysis has confirmed that 365 
the opinions and practices of clinicians in America and Europe are generally very similar 366 
and largely informed by knowledge of the relevant veterinary literature. However, the 367 
survey results have also helped to confirm that a universal approach to the management 368 
of POI does not exist and significant variation remains in relation to some of the 369 
preventative and therapeutic practices being adopted. It should be emphasized that these 370 
results are only a measure of current practice and opinions and does not provide evidence 371 
about best practice.  Further research into ways in which POI can be prevented or 372 
attenuated is essential. Recognition of these areas of research is the first step in 373 
identifying and prioritising specific areas which may benefit from future study.   374 
Footnote list: 375 
a Survey Monkey® , Palo Alto, California, USA. 376 
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